Press release
Ocimum Launches Special Tuberculosis Day Awareness Campaign
Ocimum Biosolutions offers a kit that can be simultaneously used for detection as well as typing of the Mycobacterium tuberculosis complex. This is a PCR-based method, which depends on the amplification of a highly polymorphic Direct Repeat (DR) locus in M. tuberculosis genome. This technique is highly useful for clinical samples as it can detect the causative bacteria and is capable of providing epidemiological information on strain identities. This technique has high specificity and sensitivity with clinical samples. This kit contains one membrane, positive control 1(M. tuberculosis strainH37Rv), positive control 2 (M. bovis BCG P3), Primer DRa (biotinylated) and Primer Drb.
As a part of Tuberculosis Day awareness drive, Ocimum Biosolutions calls for collaborations with researchers, scientists and organizations working to combat the global challenges in tuberculosis.
For further information, contact us at europe@ocimumbio.com.
For media-related queries, please contact:
Ms. Nazia Sultana
+91 40 66627200
pr@ocimumbio.com
About Ocimum Biosolutions
Ocimum Biosolutions is a leading integrated genomics company providing comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.
For more information, please visit www.ocimumbio.com.
Maynak Kumar
mayank.k@ocimumbio.com
Ocimum Biosolutions Ltd.
6th Floor, Reliance Classic
Road No. 1, Banjara Hills
Hyderabad - 500 034
A.P., India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ocimum Launches Special Tuberculosis Day Awareness Campaign here
News-ID: 73419 • Views: …
More Releases from Ocimum Biosolutions
Sciantis™ – Ocimum Biosolutions unveils its new software product to handle B …
cimum Biosolutions announces release of its new software product, Sciantis™, a lab process and data management platform for biologics labs. Sciantis™ helps Labs to manage Biologics development process, automate data capturing and support lab Analytics needs.
Mr. Subash Lingareddy, CFO, President of Ocimum Biosolutions, said, “Sciantis™ is our new software offering to serve Biologics companies in improving their development process and data management. This software also serves…
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and System …
Hyderabad, Andhra Pradesh, India, February 07th, 2012: The Jury of Industry experts constituted by ABLE has declared Ocimum Biosolutions as a Bioexcellence Award winner at Bio INDIA BIO 2012 event under Bioinformatics & Systems Biology Category.
Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said, “Systems Biology and Bioinformatics will be the backbone of future therapeutics and diagnostics. At Ocimum we are focusing our efforts in these areas to meet the needs of the…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…
